EN
HI
Summary
As of 4 Sep, 2026, Glaxosmithkline Pharmaceuticals stock price is ₹2958.1. During the trading session, the stock has moved between an intraday low of ₹2925.50 and an intraday high of ₹2972.80. Over the last 52 weeks, Glaxosmithkline Pharmaceuticals has traded between ₹2088.10 and ₹3120.70.
The stock has recorded a trading volume of 48,109 shares, with a market capitalization of ₹169406034. Its Average Traded Price (ATP) is ₹2951.22, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 7 @ ₹2958.10.
Glaxosmithkline Pharmaceuticals has an upper circuit limit of ₹3525.00 and a lower circuit limit of ₹2350.00. The total value traded stands at ₹14.20 CR, and the delivery percentage for the day is 57.91%.
The stock is currently traded with a market lot size of 1. Glaxosmithkline Pharmaceuticals also offers a dividend yield of 1.94%.
Glaxosmithkline Pharmaceuticals share price chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
48109.00
Market Cap
50112.00 CR
LTQ@LTP
7@2958.10
ATP
2951.22
Var Margin
15.56 %
Circuit Range
2350-3525
Delivery %
57.91 %
Value
14.20 CR
ASM/GSM
No
Market Lot
1
Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
46.55
P/B Ratio
19.73
Div. Yield
1.94
Sector P/E
41.75
Sector P/B
3.57
Sec. Div. Yield
0.5
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2955.3
Resistance
First Resistance
2980.2
Second Resistance
3022.9
Third Resistance
3047.8
Support
First Support
2912.6
Second Support
2887.7
Third Support
2845
Glaxosmithkline Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 04 2026 | 2938.9 | 2958.1 | 0.70% | 2972.8 | 2925.5 |
| Thu Sep 03 2026 | 2962.39 | 2937.5 | -0.42% | 2998 | 2930.39 |
| Wed Sep 02 2026 | 2972.6 | 2949.89 | -1.54% | 2990.1 | 2908.5 |
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
| 2024-10-29 | Quarterly Results & Interim Dividend |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Corrigendum To The Notice Of Postal Ballot Dated August 3, 2026
GlaxoSmithKline Pharmaceuticals issued a corrigendum to its August 3, 2026 postal ballot notice. This corrects a typographical error in Mr. Akshikar's basic salary, changing it from ₹2.4 crores per month to ₹24 lakhs per month, ensuring accurate information for shareholder approval.
Sep 01 2026 15:31:33
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper Publication
GlaxoSmithKline Pharmaceuticals will hold a postal ballot for the re-appointment of Mr. Bhushan Akshikar as Managing Director. The voting period is from August 14 to September 13, 2026, with results by September 15, 2026.
Aug 14 2026 16:37:33
Read More
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Biocon Ltd.
397.40
-4.60 (1.14%)
Alkem Laboratories Ltd.
5190.00
-3.00 (0.06%)
Abbott India Ltd.
26065.00
120.00 (0.46%)
Anthem Biosciences Ltd.
934.05
-16.65 (1.75%)
Ipca Laboratories Ltd.
1965.30
9.20 (0.47%)
Gland Pharma Ltd.
2932.40
24.50 (0.84%)
Ajanta Pharma Ltd.
3464.80
-56.30 (1.60%)
Narayana Hrudayalaya Ltd.
1858.50
-23.70 (1.26%)
Global Health Ltd.
1469.80
52.50 (3.70%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2958.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 46.55. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 19.73. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.75 & 3.57 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 50112.00 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3120.70 & 2088.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
